InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
56%
T+90 mean return
+0.6%
Across 16 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by KATZMANN LYNNE S, Director. Officer active across 2 companies, notably Sabra Health Care REIT, Inc.. Aggregated, 24 reports have been logged. Activity tracked since 28 May 2021. The latest transaction was filed on 28 November 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations24 total
808 shares0Common StockSEC:0001770419-25-000007:0
813 shares0Common StockSEC:0001770419-25-000005:0
8,178 shares0Common StockSEC:0001976617-25-000079:0
914 shares0Common StockSEC:0001976617-25-000066:0
946 shares0Common StockSEC:0001976617-25-000037:0
826 shares0Common StockSEC:0001862128-24-000045:0
889 shares0Common StockSEC:0001976617-24-000080:0
9,480 shares0Common StockSEC:0001976617-24-000058:0
1,076 shares0Common StockSEC:0001976617-24-000044:0
1,108 shares0Common StockSEC:0001862128-24-000019:0
1,030 shares0Common StockSEC:0001976617-23-000053:0
1,172 shares0Common StockSEC:0001862128-23-000046:0
11,382 shares0Common StockSEC:0001976617-23-000032:0
975 shares0Common StockSEC:0001976617-23-000018:0
900 shares0Common StockSEC:0001862128-23-000029:0
812 shares0Common StockSEC:0001862128-22-000104:0
684 shares0Common StockSEC:0001862128-22-000082:0
8,751 shares0Common StockSEC:0001862128-22-000062:0
534 shares0Common StockSEC:0001862128-22-000048:0
545 shares0Common StockSEC:0001862128-22-000024:0
552 shares0Common StockSEC:0001862128-21-000098:0
438 shares0Common StockSEC:0001862128-21-000072:0
6,438 shares0Common StockSEC:0001862128-21-000045:0
287 shares0Common StockSEC:0001862128-21-000025:0
24 of 24 declarations
About KATZMANN LYNNE S
Lynne S. Katzmann is a Director at Sabra Health Care REIT, Inc. She plays a key role in the governance of the company and strategic direction. Her expertise in the healthcare sector allows her to make significant contributions to board discussions.
